The Exer-Rest® technology is based upon a patented process called Whole Body Periodic Acceleration (WBPA). NIMS has extensive research demonstrating the benefits of using the Exer-Rest® as an aid to:

• Temporarily increase local circulation
• Provide temporary relief of minor aches and pains
• Support local muscle relaxation
• Increase joint mobility
• Reduce morning stiffness

NIMS announced that the FDA granted approval to market their innovative new device called the Exer-Rest®. NIMS, an ISO 13485 certified company, is now licensed to sell Exer-Rest® in the United States, Canada, the European Common Market and other major world markets. See our Press Releases section for the latest news.